Skip to main content

Advertisement

Figure 2 | BMC Research Notes

Figure 2

From: Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection

Figure 2

Residual activity in HIV-1 strains. HIV-1IIIB cell-free viruses were exposed to serial dilutions of bDLE for 5 minutes. The viruses were then ultracentrifuged, washed twice and added to HeLa-CD4-LTR-β-gal cells. After 24 hours, β-gal activity was measured. Percentage values are relative to the positive control (infected cells without bDLE treatment). The data represent the means ± standard deviations from three separate experiments, each of which was carried out in duplicate.

Back to article page